V. Bryan Lawlis, Director at BIOMARIN PHARMACEUTICAL INC (BMRN), sold 8,500 shares at $97.09 ($825K) on 2023-04-03, disclosed to the SEC on 2023-04-04.
Scheduled sale ($825k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| GERN | SELL | 2023-05-11 | $105K | — | Filing → |
| BMRN | SELL | 2022-04-18 | $356K | — | Filing → |
| BMRN | SELL | 2022-01-19 | $745K | — | Filing → |